JP2018524977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524977A5 JP2018524977A5 JP2017564424A JP2017564424A JP2018524977A5 JP 2018524977 A5 JP2018524977 A5 JP 2018524977A5 JP 2017564424 A JP2017564424 A JP 2017564424A JP 2017564424 A JP2017564424 A JP 2017564424A JP 2018524977 A5 JP2018524977 A5 JP 2018524977A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- protein
- acid sequence
- seq
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/063248 WO2015189425A1 (en) | 2014-06-13 | 2015-06-12 | Immunogenic combinations |
| GBGB1510357.5A GB201510357D0 (en) | 2015-06-12 | 2015-06-12 | Adenovirus polynucleotides and polypeptides |
| EPPCT/EP2015/063248 | 2015-06-12 | ||
| GB1510357.5 | 2015-06-12 | ||
| GB1514772.1 | 2015-08-19 | ||
| GBGB1514772.1A GB201514772D0 (en) | 2015-08-19 | 2015-08-19 | Adenovirus polynucleotides and polypeptides |
| PCT/EP2016/063297 WO2016198599A1 (en) | 2015-06-12 | 2016-06-10 | Adenovirus polynucleotides and polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524977A JP2018524977A (ja) | 2018-09-06 |
| JP2018524977A5 true JP2018524977A5 (enExample) | 2019-07-11 |
| JP6983665B2 JP6983665B2 (ja) | 2021-12-17 |
Family
ID=57503533
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564424A Expired - Fee Related JP6983665B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
| JP2017564467A Active JP6873054B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564467A Active JP6873054B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US11254711B2 (enExample) |
| EP (2) | EP3307313A1 (enExample) |
| JP (2) | JP6983665B2 (enExample) |
| KR (2) | KR102535670B1 (enExample) |
| CN (2) | CN108025058B (enExample) |
| AU (4) | AU2016275619B2 (enExample) |
| BE (1) | BE1024420B1 (enExample) |
| BR (1) | BR112017026523A2 (enExample) |
| CA (2) | CA2988654A1 (enExample) |
| EA (1) | EA038402B9 (enExample) |
| IL (2) | IL256069B2 (enExample) |
| MX (2) | MX2017016101A (enExample) |
| WO (2) | WO2016198621A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA038402B9 (ru) | 2015-06-12 | 2021-09-22 | Глаксосмитклайн Байолоджикалс Са | Аденовирусные полинуклеотиды и полипептиды |
| GB201513176D0 (en) | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| ES2959811T3 (es) * | 2016-12-09 | 2024-02-28 | Glaxosmithkline Biologicals Sa | Construcciones de adenovirus de chimpancé con antígenos de Lyssavirus |
| GB201620968D0 (en) | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| WO2019016756A1 (en) | 2017-07-21 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES |
| WO2019076892A1 (en) | 2017-10-16 | 2019-04-25 | Glaxosmithkline Biologicals Sa | ENHANCED PROMOTER |
| CN111479926A (zh) | 2017-10-16 | 2020-07-31 | 葛兰素史密丝克莱恩生物有限公司 | 具有两个表达盒的猿猴腺病毒载体 |
| SG11202003058UA (en) | 2017-10-16 | 2020-04-29 | Glaxosmithkline Biologicals Sa | Replication competent adenoviral vectors |
| US11859199B2 (en) | 2017-10-16 | 2024-01-02 | Glaxosmithkline Biologicals Sa | Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof |
| MX2020004487A (es) * | 2017-10-31 | 2020-08-13 | Janssen Vaccines & Prevention Bv | Adenovirus y usos de estos. |
| GB201721068D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B immunisation regimen and compositions |
| GB201721069D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B Immunisation regimen and compositions |
| BR112020012361A2 (pt) | 2017-12-20 | 2020-11-24 | Glaxosmithkline Biologicals S.A. | constructos de antígeno do vírus epstein-barr |
| CN112638936A (zh) * | 2018-06-12 | 2021-04-09 | 葛兰素史密丝克莱恩生物有限公司 | 腺病毒多核苷酸和多肽 |
| US20210277417A1 (en) * | 2018-06-25 | 2021-09-09 | Akouos, Inc. | Methods of treating clrn1-associated hearing loss and/or vision loss |
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| EP3810277A1 (en) * | 2018-07-20 | 2021-04-28 | Janssen Vaccines & Prevention B.V. | Recombinant adenoviral vector expressing zika antigen with improved productivity |
| US20210283238A1 (en) | 2018-08-07 | 2021-09-16 | Glaxosmithkline Biologicals Sa | Novel processes and vaccines |
| EP3897846A1 (en) | 2018-12-21 | 2021-10-27 | GlaxoSmithKline Biologicals SA | Methods of inducing an immune response |
| US20220339281A1 (en) | 2019-03-05 | 2022-10-27 | GalxoSmithKline Biologicals SA | Hepatitis b immunisation regimen and compositions |
| US20230109362A1 (en) | 2020-05-14 | 2023-04-06 | Glaxosmithkline Biologicals Sa | Viral biosensors |
| WO2025038011A1 (en) * | 2023-08-11 | 2025-02-20 | Joint Stock Company «Biocad» | Modified sequence of adenovirus e2a gene for producing vectors based on adeno-associated viruses (aav) (variants) |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919102D0 (en) * | 1989-08-22 | 1989-10-04 | Oxford Virology Ltd | A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus |
| ES2322043T3 (es) | 2001-06-22 | 2009-06-16 | The Wistar Institute Of Anatomy And Biology | Procedimientos de indusccion de una respuesta citotoxica inmune y composiciones de adenovirus de simio recombinante utiles en los mismos. |
| KR100987360B1 (ko) * | 2001-11-21 | 2010-10-12 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 원숭이 아데노바이러스 핵산과 아미노산 서열, 이를함유하는 벡터 및 사용방법 |
| US7030094B2 (en) | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| US7960522B2 (en) | 2003-01-06 | 2011-06-14 | Corixa Corporation | Certain aminoalkyl glucosaminide phosphate compounds and their use |
| US7205342B2 (en) * | 2003-10-10 | 2007-04-17 | General Electric Company | Poly(arylene ether) composition and method of molding |
| ES2871907T3 (es) | 2004-01-23 | 2021-11-02 | Msd Italia Srl | Portadores de vacuna de adenovirus de chimpancé |
| EP2848692B1 (en) | 2004-05-21 | 2017-08-16 | Novartis Vaccines and Diagnostics, Inc. | Alphavirus vectors for influenza virus vaccines |
| NZ555907A (en) * | 2004-11-16 | 2009-12-24 | Aeras Global Tb Vaccine Found | Multivalent vaccines comprising recombinant viral vectors |
| CA2608316A1 (en) * | 2005-05-12 | 2006-11-16 | Glaxo Group Limited | Vaccine composition |
| EP1893636A2 (en) * | 2005-06-17 | 2008-03-05 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Hepatitis c virus nucleic acid vaccine |
| HUE031411T2 (en) | 2007-03-02 | 2017-07-28 | Glaxosmithkline Biologicals Sa | New Methods and Preparations |
| GB0706914D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel adenovirus vectors |
| CA2706257C (en) * | 2007-11-28 | 2017-06-06 | The Trustees Of The University Of Pennsylvania | Simian subfamily b adenovirus sadv-28, -27, -29, -32, -33 and -35 and uses thereof |
| EP2220217A2 (en) | 2007-11-28 | 2010-08-25 | The Trustees of the University of Pennsylvania | Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| CN101883858B (zh) * | 2007-11-28 | 2015-07-22 | 宾夕法尼亚大学托管会 | 猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用 |
| CN102016011B (zh) * | 2008-03-04 | 2013-12-11 | 宾夕法尼亚大学托管会 | 猿猴腺病毒sadv-36、-42.1、-42.2和-44及其应用 |
| WO2009146902A1 (en) * | 2008-06-03 | 2009-12-10 | Okairòs Ag | A vaccine for the prevention and therapy of hcv infections |
| WO2010085984A1 (en) * | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| MX2011007980A (es) | 2009-02-02 | 2011-08-17 | Okairos Ag | Secuencias de acido nucleico y aminoacido de adenovirus de simio, vectores que contienen los mismos y usos de las mismas. |
| CA2762203A1 (en) * | 2009-05-29 | 2010-12-02 | Soumitra Roy | Simian adenovirus 41 and uses thereof |
| US8865182B2 (en) * | 2009-07-31 | 2014-10-21 | Paxvax, Inc. | Adenoviral-based vectors |
| WO2011130627A2 (en) * | 2010-04-16 | 2011-10-20 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Chimpanzee adenoviral vector-based filovirus vaccines |
| US20110293700A1 (en) | 2010-05-26 | 2011-12-01 | Selecta Biosciences, Inc. | Nanocarrier compositions with uncoupled adjuvant |
| GB201016471D0 (en) * | 2010-09-30 | 2010-11-17 | Isis Innovation | Viral vector immunogenic compositions |
| US20120321694A1 (en) | 2010-10-27 | 2012-12-20 | Daniel Larocque | Compositions and uses |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| GB201108879D0 (en) * | 2011-05-25 | 2011-07-06 | Isis Innovation | Vector |
| EP2729168A2 (en) | 2011-07-06 | 2014-05-14 | Novartis AG | Immunogenic compositions and uses thereof |
| FR2978457A1 (fr) * | 2011-07-27 | 2013-02-01 | Univ Paris Diderot Paris 7 | Composes contenant un vecteur viral a specificite hepatique et presentant une activite anti-inflammatoire |
| IN2014DN03005A (enExample) | 2011-10-05 | 2015-05-08 | Genvec Inc | |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| AP2014007993A0 (en) | 2012-03-22 | 2014-10-31 | Crucell Holland Bv | Vaccine against RSV |
| WO2014019718A1 (en) | 2012-08-01 | 2014-02-06 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
| BR112015011389A2 (pt) * | 2012-11-20 | 2017-08-22 | Glaxosmithkline Biologicals Sa | Complexo f do vírus sincicial respiratório, métodos para produzir um complexo f do vírus sincicial respiratório e para indução de uma resposta imunológica a um f de rsv em um indivíduo, e, composição imunogênica |
| DE102012221236A1 (de) | 2012-11-21 | 2014-05-22 | Zf Friedrichshafen Ag | Getriebe |
| GB201303406D0 (en) * | 2013-02-26 | 2013-04-10 | Health Prot Agency | Crimean-Congo Haemorrhagic Fever Virus Antigenic Composition |
| KR102039520B1 (ko) | 2013-04-18 | 2019-11-01 | 이뮨 디자인 코포레이션 | 암 치료에 이용하기 위한 gla 단일요법 |
| CN103937835A (zh) * | 2013-08-19 | 2014-07-23 | 中国科学院上海巴斯德研究所 | 一种基于腺病毒AdC68的表达载体及其构建方法 |
| CN103923943B (zh) * | 2013-08-19 | 2019-01-22 | 中国科学院上海巴斯德研究所 | 一种基于腺病毒AdC7的表达载体及其构建方法 |
| GB201318084D0 (en) * | 2013-10-11 | 2013-11-27 | Isis Innovation | Malaria vaccination |
| CN106659777A (zh) | 2014-06-13 | 2017-05-10 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合产品 |
| EA038402B9 (ru) | 2015-06-12 | 2021-09-22 | Глаксосмитклайн Байолоджикалс Са | Аденовирусные полинуклеотиды и полипептиды |
-
2016
- 2016-06-10 EA EA201792651A patent/EA038402B9/ru unknown
- 2016-06-10 EP EP16730315.5A patent/EP3307313A1/en active Pending
- 2016-06-10 JP JP2017564424A patent/JP6983665B2/ja not_active Expired - Fee Related
- 2016-06-10 KR KR1020177037436A patent/KR102535670B1/ko active Active
- 2016-06-10 EP EP16730773.5A patent/EP3307314A1/en not_active Withdrawn
- 2016-06-10 WO PCT/EP2016/063329 patent/WO2016198621A1/en not_active Ceased
- 2016-06-10 WO PCT/EP2016/063297 patent/WO2016198599A1/en not_active Ceased
- 2016-06-10 US US15/735,872 patent/US11254711B2/en active Active
- 2016-06-10 AU AU2016275619A patent/AU2016275619B2/en active Active
- 2016-06-10 CN CN201680047775.1A patent/CN108025058B/zh not_active Expired - Fee Related
- 2016-06-10 MX MX2017016101A patent/MX2017016101A/es unknown
- 2016-06-10 MX MX2017016105A patent/MX2017016105A/es unknown
- 2016-06-10 AU AU2016275601A patent/AU2016275601A1/en not_active Abandoned
- 2016-06-10 US US15/735,839 patent/US11254710B2/en active Active
- 2016-06-10 KR KR1020187000991A patent/KR20180012857A/ko not_active Ceased
- 2016-06-10 JP JP2017564467A patent/JP6873054B2/ja active Active
- 2016-06-10 CA CA2988654A patent/CA2988654A1/en active Pending
- 2016-06-10 BR BR112017026523A patent/BR112017026523A2/pt not_active IP Right Cessation
- 2016-06-10 CA CA2988481A patent/CA2988481A1/en active Pending
- 2016-06-10 BE BE2016/5434A patent/BE1024420B1/fr active IP Right Grant
- 2016-06-10 CN CN201680047373.1A patent/CN107921118B/zh active Active
-
2017
- 2017-12-03 IL IL256069A patent/IL256069B2/en unknown
- 2017-12-05 IL IL256121A patent/IL256121B2/en unknown
-
2019
- 2019-03-26 AU AU2019202081A patent/AU2019202081B2/en active Active
- 2019-11-27 AU AU2019271972A patent/AU2019271972B2/en not_active Ceased
-
2021
- 2021-12-30 US US17/565,796 patent/US20220204566A1/en not_active Abandoned
-
2022
- 2022-01-25 US US17/583,511 patent/US20220220157A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018524977A5 (enExample) | ||
| JP2020511114A5 (enExample) | ||
| JP7274222B2 (ja) | 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用 | |
| JP2018523980A5 (enExample) | ||
| JP2020511940A5 (enExample) | ||
| CN105112428B (zh) | 猿腺病毒核酸和氨基酸序列，包含其的载体及其用途 | |
| CN107921118B (zh) | 腺病毒多核苷酸和多肽 | |
| ES2898235T3 (es) | Secuencias de aminoácidos y de ácidos nucleicos de adenovirus de simio, vectores que las contienen, y sus usos | |
| JP2015057052A5 (enExample) | ||
| JP2012516679A5 (enExample) | ||
| CN110300597A (zh) | 腺病毒多核苷酸和多肽 | |
| EP3655539A1 (en) | Chikungunya virus antigen constructs | |
| CN112638936A (zh) | 腺病毒多核苷酸和多肽 | |
| US20240002879A1 (en) | Gorilla adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| US7687615B2 (en) | PAV regions for encapsidation and E1 transcriptional control | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| JPWO2021019235A5 (enExample) |